Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Raguu17on Sep 17, 2019 2:19pm
107 Views
Post# 30136536

RE:Selling is not over yet

RE:Selling is not over yetCam claimed we were declining all deals last year when we were in the teens because we weren't gettting propper value for future worth. (As they were handing out premium laced deals). Now at a fraction of the previous value we are gonna take a deal? 

The market is pricing in the expected future dilution. They expect Booth and the Band to continue their shopping ways. They expect them to over pay and use shares AGAIN. 

This is how bad their reputation is. Deals that aren't even being discussed are already being seen as ultra dilutive and slow on revenue. 

The irony that this devaluation will be what stops this hypothetical dilutive deal is funny.






HappyTrader69 wrote: We need to retest the 52 week low of $6.21. The shorts have no fear......the only salvation to the decline is an announcement of a partnership with a package goods company.


Bullboard Posts